News
News
- CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook
12/19/2019 / 14:03 - GlobeNewswire - On February 26, 2020 America’s Most Successful Play Takes Center Stage at the World’s Most Famous Arena
12/18/2019 / 15:45 - GlobeNewswire - Cytokinetics Granted Orphan Drug Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis
12/18/2019 / 13:30 - GlobeNewswire - Neoleukin Therapeutics Announces Pricing of $75.0 Million Public Offering
12/18/2019 / 04:26 - GlobeNewswire - The Lancet Publishes Phase 3 Trial Results for Zogenix Investigational Drug FINTEPLA® in Dravet Syndrome
12/18/2019 / 01:04 - GlobeNewswire - Neoleukin Therapeutics Announces Proposed Public Offering of Common Stock
12/17/2019 / 22:38 - GlobeNewswire - CytomX Therapeutics Announces New Employment Inducement Grants
12/17/2019 / 22:03 - GlobeNewswire - Greenway Technologies Announces Results of Special Shareholders Meeting Held December 11, 2019
12/16/2019 / 21:42 - GlobeNewswire - Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk
12/13/2019 / 22:49 - GlobeNewswire - XP Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
12/13/2019 / 18:11 - GlobeNewswire
Real-time